Last Price$59.76.8%
Market Cap$3,532.4M
12.4x
Industry median - 5.2x
5Y Historical average - 9.3x
(2.2x)
Industry median - 1.4x
5Y Historical average - 2.3x
FCF to Interest
N/A
Industry median - (11.6x)
5Y Historical average - (209.4x)
1.6%
Industry median - 4.2%
5Y Historical average - 3.4%
PTGX Health Rating
PTGX Health rating
6.5
PTGX Health rating performance
PTGX Financial Stability & Strength
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
FCF to Interest
Intangibles as % of Total Assets
Competing with PTGX Financial Health
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Net Debt | Health score | Current ratio | Quick ratio | Net Debt to FCF | FCF to Interest | Intangibles as % of Total Assets | Total Debt to Equity |
$3,532.4M | ($408.0M) | 6.5 | 12.5x | 12.4x | (2.2x) | N/A | 0.0% | 1.6% | |
$124.8B | ($4,366.4M) | 5.8 | 2.7x | 2.2x | 5.5x | (25.8x) | 3.7% | 10.7% | |
$77.0B | ($15.9B) | 6.6 | 33.5x | 29.7x | (4.4x) | 65.2x | 3.0% | 5.7% | |
$34.4B | N/A | 5.6 | N/A | N/A | N/A | (103.5x) | N/A | N/A | |
$30.7B | ($1,398.5M) | 6.9 | 2.8x | 2.6x | 32.8x | (0.3x) | 0.0% | 1,931.9% | |
$24.0B | (€16.5B) | 6.8 | 7.5x | 7.3x | 71.9x | (11.5x) | 3.5% | 1.3% | |
$14.5B | $5,841.4M | 4.7 | 1.4x | 1.4x | 2.1x | 12.3x | 0.0% | 73.6% | |
$13.8B | ($2,967.0M) | 6.9 | 5.2x | 4.8x | (2.7x) | 25.2x | 1.1% | 4.7% | |
$13.4B | ($535.0M) | 6.1 | 5.3x | 3.0x | (1.1x) | 38.5x | 3.7% | 10.7% | |
$13.3B | ($405.1M) | 6.8 | 10.2x | 9.9x | 2.9x | (16.4x) | 0.0% | 1.9% | |
$1,846.9M | ($1,600.5M) | 4.3 | 1.9x | 1.6x | 1.5x | N/A | 0.9% | 32.1% |
FAQ
What is the Protagonist Therapeutics, Inc. (PTGX) quick ratio?
The Protagonist Therapeutics, Inc. (PTGX) quick ratio is 12.4x, compared to the industry median of 5.2x and the 5-year historical average of 9.3x.
What is the Protagonist Therapeutics, Inc. (PTGX) net debt to Free Cash Flow (FCF) ratio?
The Protagonist Therapeutics, Inc. (PTGX) net debt to FCF ratio is (2.2x), compared to the industry median of 1.4x and the 5-year historical average of (2.3x).
What is Protagonist Therapeutics, Inc. (PTGX) Free Cash Flow (FCF) to interest ratio?
Protagonist Therapeutics, Inc. (PTGX) FCF to interest ratio is N/A, compared to the industry median of (11.6x) and the 5-year historical average of (209.4x).
What is the Protagonist Therapeutics, Inc. (PTGX) total debt to equity ratio?
The Protagonist Therapeutics, Inc. (PTGX) total debt to equity ratio is 1.6%, compared to the industry median of 4.2% and the 5-year historical average of 3.4%.